IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.00
+0.50 (6.67%)
Sep 4, 2026, 3:58 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 16.35 million as of September 4, 2026. Its market cap has increased by 48.92% in one year.
Market Cap
16.35M
Enterprise Value
15.24M
Revenue
7.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 16.35M, an increase of 85.37%. That is a compound annual growth rate of 4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 16.35M | 50.19% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 35.63M |
| Arecor Therapeutics | 27.94M |
| SkinBioTherapeutics | 24.62M |
| ImmuPharma | 21.87M |
| Palatin Technologies | 16.44M |
| Fusion Antibodies | 15.02M |
| Aptamer Group | 12.09M |
| Genflow Biosciences | 11.89M |